Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionTd Asset Management Inc
Latest Disclosed Ownership312,762 shares
Latest Disclosed Value $ 18,174,600
Td Asset Management Inc reports 14.01% decrease in ownership of PCVX / Vaxcyte, Inc.

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 312,762 shares of Vaxcyte, Inc. (US:PCVX) valued at $18,174,600 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 363,734 shares of Vaxcyte, Inc.. This represents a change in shares of -14.01% during the quarter. The current value of the position is $15,250,275 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F VAXCYTE COM 92243G108 312,762 -50,972 -14.01 18,175 8.29 0.0079
2026-02-10 2025-12-31 13F VAXCYTE COM 92243G108 363,734 -34,746 -8.72 16,783 16.92 0.0135
2025-11-10 2025-09-30 13F VAXCYTE COM 92243G108 398,480 -141,304 -26.18 14,353 -18.21 0.0117
2025-07-28 2025-06-30 13F VAXCYTE COM 92243G108 539,784 236,188 77.80 17,548 53.08 0.0150
2025-05-07 2025-03-31 13F VAXCYTE COM 92243G108 303,596 -30,160 -9.04 11,464 -58.04 0.0106
2025-02-11 2024-12-31 13F VAXCYTE COM 92243G108 333,756 -32,400 -8.85 27,321 -34.05 0.0242
2024-11-01 2024-09-30 13F VAXCYTE COM 92243G108 366,156 53,730 17.20 41,427 75.60 0.0366
2024-08-02 2024-06-30 13F VAXCYTE COM 92243G108 312,426 31,138 11.07 23,591 22.78 0.0220
2024-05-08 2024-03-31 13F VAXCYTE COM 92243G108 281,288 114,252 68.40 19,215 83.18 0.0179
2024-02-12 2023-12-31 13F VAXCYTE COM 92243G108 167,036 15,890 10.51 10,490 36.13 0.0103
2023-10-27 2023-09-30 13F VAXCYTE COM 92243G108 151,146 62,101 69.74 7,705 73.30 0.0093
2023-08-09 2023-06-30 13F VAXCYTE COM 92243G108 89,045 69,845 363.78 4,447 518.36 0.0051
2023-05-10 2023-03-31 13F VAXCYTE COM 92243G108 19,200 5,644 41.63 720 10.62 0.0009
2023-02-07 2022-12-31 13F VAXCYTE COM 92243G108 13,556 13,556 650 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.